Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;64(2):149-56.
doi: 10.1007/s00005-015-0367-5. Epub 2015 Oct 6.

Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand

Affiliations

Studies on Immunogenicity and Antigenicity of Baculovirus-Expressed Binding Region of Plasmodium falciparum EBA-140 Merozoite Ligand

Agata Zerka et al. Arch Immunol Ther Exp (Warsz). 2016 Apr.

Erratum in

Abstract

The erythrocyte binding ligand 140 (EBA-140) is a member of the Plasmodium falciparum erythrocyte binding antigens (EBA) family, which are considered as prospective candidates for malaria vaccine development. EBA proteins were identified as important targets for naturally acquired inhibitory antibodies. Natural antibody response against EBA-140 ligand was found in individuals living in malaria-endemic areas. The EBA-140 ligand is a paralogue of the well-characterized P. falciparum EBA-175 protein. They both share homology of domain structure, including the binding region (Region II), which consists of two homologous F1 and F2 domains and is responsible for ligand-erythrocyte receptor interaction during merozoite invasion. It was shown that the erythrocyte receptor for EBA-140 ligand is glycophorin C-a minor human erythrocyte sialoglycoprotein. In studies on the immunogenicity of P. falciparum EBA ligands, the recombinant proteins are of great importance. In this report, we have demonstrated that the recombinant baculovirus-obtained EBA-140 Region II is immunogenic and antigenic. It can raise specific antibodies in rabbits, and it is recognized by natural antibodies present in sera of patients with malaria, and thus, it may be considered for inclusion in multicomponent blood-stage vaccines.

Keywords: Antigenicity; Immunogenicity; Natural anti-EBA-140 IgG antibodies; Plasmodium falciparum; Recombinant binding region of EBA-140 ligand; Region II baculovirus expression.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Recognition of the recombinant EBA-140 Region II (RII) and its F2 domain fragment by MoAb (anti-myc, clone 9E10) and polyclonal rabbit antibodies (anti-RII) in Western blotting; bovine serum albumin (BSA), negative control
Fig. 2
Fig. 2
Binding of rabbit antibodies to the recombinant EBA-140 Region II and F2 domain fragment in ELISA (a). MoAb anti-myc (clone 9E10) was used as a positive binding control (b); BSA, negative control
Fig. 3
Fig. 3
a Binding of the recombinant EBA-140 Region II (RII) to human erythrocytes mesured in flow cytometry; b Inhibition of the erythrocyte binding of the recombinant EBA-140 Region II by rabbit antibodies (anti-RII)
Fig. 4
Fig. 4
Reactivity of human sera from persons with acute malaria (group 1, n = 25) and with the history of Plasmodium infection confirmed by serological examination (group 2, n = 11) with the recombinant EBA-140 Region II in ELISA

Similar articles

Cited by

References

    1. Adams JH, Blair PL, Kaneko O, et al. An expanding ebl family of Plasmodium falciparum. Trends Parasitol. 2001;17:297–299. doi: 10.1016/S1471-4922(01)01948-1. - DOI - PubMed
    1. Ahmed Ismail H, Tijani MK, Langer C, et al. Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria. Malar J. 2014;13:425. doi: 10.1186/1475-2875-13-425. - DOI - PMC - PubMed
    1. Ashline DJ, Duk M, Lukasiewicz J, et al. The structures of glycophorin C N-glycans, a putative component of Plasmodium falciparum EBA-140 ligand. Glycobiology. 2015;25:570–581. doi: 10.1093/glycob/cwu188. - DOI - PMC - PubMed
    1. Bei AK, Duraisingh MT. Functional analysis of erythrocyte determinants of Plasmodium infection. Int J Parasitol. 2012;42:575–582. doi: 10.1016/j.ijpara.2012.03.006. - DOI - PMC - PubMed
    1. Bergmann-Leitner ES, Mease RM, De La Vega P, et al. Immunization with pre-erythrocytic antigen CelTOS from Plasmodium falciparum elicits cross-species protection against heterologous challenge with Plasmodium berghei. PLoS One. 2010;5:e12294. doi: 10.1371/journal.pone.0012294. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources